placeholder image
M. S. LeDoux All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson's disease. 
    Nat Aging. 2026
  • A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. 
    Neurology. 2017
  • Treatment of myoclonus-dystonia syndrome with tetrabenazine. 
    Parkinsonism & Related Disorders. 2014
    • Review
  • Incomplete nonsense-mediated decay facilitates detection of a multi-exonic deletion mutation in SGCE [review]. 
    Clinical Genetics. 2013
    • Contact
    full name
  • M. S. LeDoux
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration